Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Can India's Pharma Thrive Amid US Tariff Threats? Union Minister Piyush Goyal Meets Industry Leaders
Union Minister of Commerce and Industry, Piyush Goyal, held an interaction with key stakeholders from India's pharmaceutical ecosystem, focusing on strengthening industry growth and regulatory reforms. In a social media post on Monday, the minister…
Why Trump's Obesity Drug 'Deal' Will Help Big Pharma Most Of All
Should the rooster get credit for the sun rising in the morning? Hardly. Yet in recent weeks, two companies received significant financial benefits for taking actions that market forces were likely going to bring about on their own. The agreement…
At 21x P/E, is Lupin an undervalued pharma giant poised for the next growth cycle?
India is often called the “pharmacy of the world” because it is a leading global supplier of generic medicines and vaccines. Lupin was one of the beneficiaries, becoming the third-largest generic company in the US by number of…
Innocan Pharma Announces Promising Translational Evidence from a Pain Relief Study of Repeated LPT-CBD Administration in Goats
Two goats suffering from chronic and disabling painful condition were treated with subcutaneous Synthetic Liposomal Cannabidiol (LPT-CBD, 5 mg/kg) injections every six weeks for 10 months. Throughout the study, serial blood sampling was performed…
Pharma Pushes Back on State PFAS Regulations
In January 2025, Minnesota's law regulating PFAS, a class of synthetic chemicals used to make products resistant to heat, grease, oil, and water, came into effect. The statute, one of the strongest of its kind in the United States, banned the…
Sudeep Pharma IPO Day 3: Sees strong traction, Should you bid?
Sudeep Pharma's IPO continued its strong momentum as it entered the final day of bidding, with the issue subscribed 5.09 times by the end of day two. The surge has been driven largely by non-institutional investors (NIIs), who have subscribed 12.00…
BridgeBio Pharma (NASDAQ:BBIO) Sets New 52-Week High - Time to Buy?
BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report)'s stock price hit a new 52-week high on Monday. The company traded as high as $69.89 and last traded at $69.6870, with a volume of 160191 shares. The stock had previously closed at $68.11.
Ascentage Pharma Group International (NASDAQ:AAPG) Coverage Initiated at Truist Financial
Equities researchers at Truist Financial assumed coverage on shares of Ascentage Pharma Group International (NASDAQ:AAPG - Get Free Report) in a research report issued to clients and investors on Monday. The firm set a 'buy' rating on the stock. A…
Vestor Capital LLC Sells 399,100 Shares of Royalty Pharma PLC $RPRX
Vestor Capital LLC lowered its holdings in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 98.6% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,636 shares of…
DNB Asset Management AS Increases Position in Royalty Pharma PLC $RPRX
DNB Asset Management AS boosted its holdings in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 13.9% in the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 76,835 shares of the biopharmaceutical…
Horizon Kinetics Asset Management LLC Boosts Stake in Royalty Pharma PLC $RPRX
Horizon Kinetics Asset Management LLC raised its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 7.3% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The…
Online abuse drives young women out of Swiss politics, study finds
According to the study, young politicians in Switzerland face online abuse at similar rates. But the nature of the hostility varies sharply depending on whether the target is a woman or a man. Women are far more likely to face attacks linked to…
Mediolanum International Funds Ltd Has $2.01 Million Stock Holdings in Royalty Pharma PLC $RPRX
Mediolanum International Funds Ltd trimmed its position in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 57.4% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 56,018 shares of the…
Beauty market aglow: young Chinese splurge on self-care, Fosun-backed firm says
Young Chinese consumers, including a growing number of men, are splurging on aesthetic medical treatments for physical, emotional and social wellness, according to the CEO of Fosun Pharma‑backed Sisram Medical and its subsidiary Alma, who…
Health Care Roundup: Market Talk
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 0803 GMT – CSPC Pharmaceutical Group's growth visibility for next year appears clouded to UOB Kay Hian…
Receive a Daily briefing on Pharma Industry News
Get Started